| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $294.3M | +64.1% |
| Cost of Revenue | $19.6M | +5.2% |
| R&D Expense | $33.3M | +42.4% |
| SG&A Expense | $115.9M | +2.5% |
| Operating Income | $125.5M | +418.6% |
| Pre-tax Income | $121.8M | +563.3% |
| Income Tax | -$245.2M | — |
| Net Income | $367.0M | +1999.1% |
| EPS (Basic) | $20.40 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $40.6M | -28.5% |
| Short-term Investments | $114.4M | +455.9% |
| Accounts Receivable | $51.8M | +24.4% |
| Inventory | $11.5M | +91.7% |
| Current Assets | $240.2M | +77.8% |
| Total Assets | $513.6M | +213.2% |
| Current Liabilities | $99.2M | +56.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $75.7M | +140.4% |
| Investing Cash Flow | -$92.4M | -2336.4% |
| Financing Cash Flow | $601K | +105.2% |
| +1960.6% |
| EPS (Diluted) | $19.48 | +1867.7% |
| Long-term Debt |
| $52.5M |
| -12.5% |
| Total Liabilities | $122.1M | -24.0% |
| Stockholders' Equity | $391.5M | — |